Replies to post #10927 on ANI Pharmaceuticals (ANIP)

[jacob613]

I don’t think covid has anything to do with this stock. Taking earnings guidance way down destroyed it (and two consecutive missed quarters) Volume was higher when we had a convert. The convert covering drove stock to 80’s. Now we have all the “noise” out. And a reset of base ebitda to 83mm. It should charge higher over time. Expectations sufficiently low for this.